http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2453274-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f4811785c34164a44980adf6bffbd1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d7f1ffab8b58f4cb25cdc70a34b9092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4339c36df3f1c3bc2cf13ddc0a14611b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B8-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-04
filingDate 2010-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3b509b9d562176d9d35bfa81015b133
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b2fde3e8c2df2f7560c2467ca931902
publicationDate 2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2453274-C1
titleOfInvention Method of selecting tactics of treating puerperas with post-natal purulent-septic diseases
abstract FIELD: medicine. n SUBSTANCE: invention relates to medicine, obstetrics, gynecology and includes estimation of puerperas' state, depending on which treatment tactics is selected. Severity of state is estimated by two groups of criteria of table No 3, presented in the description, by 1 point: absence of factors of risk of purulent-septic complications (PSC), subfebrile condition with single rise to 38°C, arrested by antibacterial therapy (ABT), absence of easily arrested intestine paresis after Cesarean section, the cervix of uterus is formed, presence of uterus involution in hysteroscopy at the background of treatment with endometrectomy or vacuum-aspiration, USE-data - increase and extension of uterus cavity by 0.5-1.0 cm, absence of deformation in the area of scar or deformation up to 0.5 cm, on uterus walls - linear echo-positive structures up to 0.2-0.3 cm thick, local sections of reduced myometrium echogenicity in the region of scars not larger than 1.5x1.5 cm, absence of infiltration, hematoma in the region of scars, improvement of laboratory indices in dynamics. Criteria of group 2 are estimated in 2 points: presence of PSC risk factors, long-lasting fever with resumption after finishing ABT, intestine paresis with absence of effect from intensive or repeated treatment courses, absence of tendency to formation of uterus cervix, stable uterus subinvolution, by USE data: extension of uterus cavity ≥1 cm, deformation in scar ≥0.5 cm, echopositive structures ≥0.4 cm, reduces echogenicity in scar zone ≥2.5×1.5 cm, hematoma or infiltrate in retrovesical space, in area of scars, absence of positive dynamics or change of laboratory indices to the worse. If state of puerpera is characterised by criteria of the first group to 7 points, it is estimated as uncomplicated form of disease, if - more than 7 points or at least by one criterion from group 2, as complicated form. n EFFECT: method ensures reliable justification of adequate tactics of patient management, strict control of their state in dynamics, reduction of frequency of complicated generalised forms of PSC, terms of staying in hospital. n 2 ex, 3 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2623449-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2802432-C1
priorityDate 2010-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2276357-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2170061-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-2377-F1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID57210135
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2147
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2875
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1251836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID60667272
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID55590735
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP63499
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID57469701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100537633
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2539795
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1798
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID76282
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID451158
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID66671444
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ19AZ8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID61331384
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280685
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56963851
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID66939874
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6800562
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13478
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1024293
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID57990680
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID61603107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6010
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403086
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID45957157
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID45052093
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7962317
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56904445
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5656924
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56731807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479766
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCAAC63054
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID27367
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID60851377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588349
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56470774
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43736
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID61614219
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14061
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID61346842
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81670
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID57243297
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8458
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID944817
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5R537
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID250453
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID61752993
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID57975493
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19221
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID61480213
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID75205729
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID49787044
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395306
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID325881
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00734
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP18292
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24167418
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID539188
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID62225722
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID60901531
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID914363
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID45665576
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29251
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP9WQ90
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP9WQ91
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID549559

Total number of triples: 98.